FUNDC1: An Emerging Mitochondrial and MAMs Protein for Mitochondrial Quality Control in Heart Diseases

Area of Science:

• Mitochondrial biology
• Cardiovascular research
• Cellular quality control mechanisms

Background:

• Heart diseases (HDs) are a leading global cause of death, often linked to mitochondrial dysfunction.
• Mitochondrial Quality Control (MQC) is crucial for cellular health, with the FUNDC1 protein playing a key role.
• FUNDC1's phosphorylation and expression levels impact cardiac injury, influencing various heart conditions.

Purpose of the Study:

• To consolidate and summarize current evidence on the role of FUNDC1 in MQC.
• To elucidate the association between FUNDC1 and prevalent heart diseases.
• To explore the potential of exercise in modulating FUNDC1 activity for cardiovascular health.

Main Methods:

• Literature review of studies investigating FUNDC1 in MQC and heart disease.
• Analysis of research on FUNDC1 expression and phosphorylation in various cardiac conditions.
• Examination of the link between exercise, the AMPK/FUNDC1 pathway, and cardiac function.

Main Results:

• FUNDC1 expression is elevated in metabolic cardiomyopathy (MCM) but reduced in cardiac remodeling, heart failure, and ischemia-reperfusion (IR) injury.
• FUNDC1 exhibits divergent effects on mitochondrial function across different heart diseases.
• Exercise may enhance cardiac function via the AMPK/FUNDC1 pathway.

Conclusions:

• FUNDC1 is a critical regulator in MQC with significant implications for heart disease pathogenesis.
• Understanding FUNDC1's role offers insights into therapeutic strategies for various cardiac conditions.
• Exercise emerges as a promising intervention, potentially mediated by the AMPK/FUNDC1 axis, for preventing and treating heart disease.